Christophe Jean
At a glance: Christophe Jean is Director at Rhythm Pharmaceuticals (RYTM). Their latest SEC Form 4, filed Nov 18, 2026, reported a sale of $534K. On file: 0 purchase lines ($0) and 3 sale lines ($1.1M).
Disclosed holdings: about $1.4M of RYTM stock: 11,712 shares reported on their latest Form 4 (filed Nov 18, 2026), valued at the Nov 19, 2026 close of $116.97. This counts only RYTM shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Rhythm Pharmaceuticals, Inc. (RYTM)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Christophe Jean's InsiderPrint
3 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.
Reading this print: Almost only sells, trading about 3 times a year, typically $288K a trade; most sales are on a pre-planned 10b5-1 schedule.
- Bump outward: a purchase (0)
- Dent inward: a sale (3)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Chris SteddumCFO · TPL · 100% match
- John D. Longley Jr.COO, President · OMEX · 100% match
- Jeffrey R. KlinglerCOO · WS · 100% match
- Jeremy CoxCTO · HPE · 100% match
- Lizette Benedi HerraizGeneral Counsel · STRA · 100% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 18SEC | RYTMRhythm Pharmaceuticals, Inc. | Sell Plan | 5,00016,712 held (−23%) | $106.81 | $534K | +9.5% |
| Nov 18SEC | RYTMRhythm Pharmaceuticals, Inc. | Sell Plan | 2,50014,212 held (−15%) | $110.00 | $275K | +6.3% |
| Nov 18SEC | RYTMRhythm Pharmaceuticals, Inc. | Sell Plan | 2,50011,712 held (−18%) | $115.00 | $288K | +1.7% |
- Sell
Director Christophe Jean sold $534K of RYTM at $106.81 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Christophe Jean sold $275K of RYTM at $110.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Christophe Jean sold $288K of RYTM at $115.00 — pre-scheduled 10b5-1 plan sale.
Follow Christophe Jean
Get one email when Christophe Jean files a new purchase or sale. Free.
At most one email a day about Christophe Jean, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.